Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
Bas W.G. van Rhijn(The Netherlands Cancer Institute), François Radvanyi(Hôpitaux Universitaires Henri-Mondor), Ellen C. Zwarthoff(Erasmus MC), Jean Paul Thiery(Centre National de la Recherche Scientifique), A. de Vries(Meertens Institute), Theodorus van der Kwast(Erasmus MC), Jacky Bonaventure, Angela A.G. van Tilborg(Erasmus MC), Irene Lurkin(Erasmus University Rotterdam)
Cited by 150
Related Papers
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
|Cell|2022|1.7k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654